Nurix Therapeutics IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 24.15 USD | 25,085 USD | 8,195 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 33 USD | 10 | 6 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 103.781.683 | 17,52 | 7,71 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Nurix Therapeutics Inc
Mitarbeiter 317
Handelsplatz NASDAQ
Ticker Symbol NRIX
IPO Datum 2020-07-24
Adresse 1600 Sierra Point Parkway, Brisbane, CA, United States, 94005
Webseite https://www.nurixtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Arthur T. Sands M.D., Ph.D. | CEO, President & Director |
| 2 | Mr. Johannes Van Houte | Chief Financial Officer |
| 3 | Dr. Gwenn M. Hansen Ph.D. | Chief Scientific Officer |
| 4 | Dr. Christine Ring J.D., Ph.D. | Chief Legal Officer, Secretary & Chief Compliance Officer |
| 5 | Dr. John Kuriyan Ph.D. | Founder & Member of Scientific Advisory Board |
| 6 | Dr. Arthur Weiss M.D., Ph.D. | Founder & Member of Scientific Advisory Board |
| 7 | Rita Kwong | Senior Accounting Manager |
| 8 | Dr. Pasit Phiasivongsa Ph.D. | Chief Technical Officer |
| 9 | Dr. Jason Kantor Ph.D. | Chief Business Officer |
| 10 | Mr. Christopher B. Phelps Ph.D. | Senior VP & Head of Early Drug Discovery |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 3 | Vestal Point Capital LP | 0,00% | 0,00 Mio. USD |
| 4 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 6 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 8 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 9 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 10 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | General Atlantic Llc | 0,00% | 0,00 Mio. USD |
| 12 | Perceptive Advisors LLC | 0,00% | 0,00 Mio. USD |
| 13 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | Pictet Asset Manangement SA | 0,00% | 0,00 Mio. USD |
| 15 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Rubric Capital Management LP | 0,00% | 0,00 Mio. USD |
| 17 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |
| 18 | COMMODORE CAPITAL LP | 0,00% | 0,00 Mio. USD |
| 19 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 20 | Trails Edge Capital Partners, LP | 0,00% | 0,00 Mio. USD |